(688163)"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 688163 · · 12 pages · Chinese
Shanghai Serum Bio-Technology Co., Ltd. on 6ix
Earlier from Shanghai Serum Bio-Technology
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Voluntary Disclosure of Receipt of the Certificate of GMP Compliance from the Philippines
- Announcement on Departure of a Director, Senior Management Member and Core Technical Personnel, By-election of a Director and Adjustment of Core Technical Personnel
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry
Later from Shanghai Serum Bio-Technology
All Shanghai Serum Bio-Technology news releasesFollow Shanghai Serum Bio-Technology into a list and get an email when it puts out news.
Follow Shanghai Serum Bio-Technology